A citation-based method for searching scientific literature

Yazhou Li, Xiemin Cao, Li-Xin Li, Patricia L Brubaker, Helena Edlund, Daniel J Drucker. Diabetes 2005
Times Cited: 151







List of co-cited articles
1621 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis.
Yazhou Li, Tanya Hansotia, Bernardo Yusta, Frederic Ris, Philippe A Halban, Daniel J Drucker. J Biol Chem 2003
464
25


Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets.
Loredana Farilla, Angela Bulotta, Boaz Hirshberg, Sergio Li Calzi, Nasif Khoury, Houtan Noushmehr, Cristina Bertolotto, Umberto Di Mario, David M Harlan, Riccardo Perfetti. Endocrinology 2003
473
20

Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes.
Alexandra E Butler, Juliette Janson, Susan Bonner-Weir, Robert Ritzel, Robert A Rizza, Peter C Butler. Diabetes 2003
19

Biology of incretins: GLP-1 and GIP.
Laurie L Baggio, Daniel J Drucker. Gastroenterology 2007
18

The biology of incretin hormones.
Daniel J Drucker. Cell Metab 2006
17

Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas.
D A Stoffers, T J Kieffer, M A Hussain, D J Drucker, S Bonner-Weir, J F Habener, J M Egan. Diabetes 2000
453
17



Glucagon-like peptide-1 prevents beta cell glucolipotoxicity.
J Buteau, W El-Assaad, C J Rhodes, L Rosenberg, E Joly, M Prentki. Diabetologia 2004
243
15

The physiology of glucagon-like peptide 1.
Jens Juul Holst. Physiol Rev 2007
15

Exendin-4 uses Irs2 signaling to mediate pancreatic beta cell growth and function.
Sunmin Park, Xiaocheng Dong, Tracy L Fisher, Sarah Dunn, A Kadir Omer, Gordon Weir, Morris F White. J Biol Chem 2006
157
15

Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line.
D J Drucker, J Philippe, S Mojsov, W L Chick, J F Habener. Proc Natl Acad Sci U S A 1987
619
15



Glucagon-like peptide-1 7-36: a physiological incretin in man.
B Kreymann, G Williams, M A Ghatei, S R Bloom. Lancet 1987
13

Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways.
Kiwon Ban, M Hossein Noyan-Ashraf, Judith Hoefer, Steffen-Sebastian Bolz, Daniel J Drucker, Mansoor Husain. Circulation 2008
727
13



Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats.
Loredana Farilla, Hongxiang Hui, Cristina Bertolotto, Elizabeth Kang, Angela Bulotta, Umberto Di Mario, Riccardo Perfetti. Endocrinology 2002
380
13


Glucagon-like peptide-1 regulates the beta cell transcription factor, PDX-1, in insulinoma cells.
X Wang, C M Cahill, M A Piñeyro, J Zhou, M E Doyle, J M Egan. Endocrinology 1999
102
12

GLP-1 receptor activation improves beta cell function and survival following induction of endoplasmic reticulum stress.
Bernardo Yusta, Laurie L Baggio, Jennifer L Estall, Jackie A Koehler, Dianne P Holland, Hongyun Li, Danny Pipeleers, Zhidong Ling, Daniel J Drucker. Cell Metab 2006
285
12






cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2.
Ulupi S Jhala, Gianluca Canettieri, Robert A Screaton, Rohit N Kulkarni, Stan Krajewski, John Reed, John Walker, Xueying Lin, Morris White, Marc Montminy. Genes Dev 2003
416
11




Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation.
Yuval Dor, Juliana Brown, Olga I Martinez, Douglas A Melton. Nature 2004
10



Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene.
L A Scrocchi, T J Brown, N MaClusky, P L Brubaker, A B Auerbach, A L Joyner, D J Drucker. Nat Med 1996
576
10

Increased islet apoptosis in Pdx1+/- mice.
James D Johnson, Noreen T Ahmed, Dan S Luciani, Zhiqiang Han, Hung Tran, Jun Fujita, Stanley Misler, Helena Edlund, Kenneth S Polonsky. J Clin Invest 2003
270
10


NEW INTERPRETATION OF ORAL GLUCOSE TOLERANCE.
N MCINTYRE, C D HOLDSWORTH, D S TURNER. Lancet 1964
562
9


A role for glucagon-like peptide-1 in the central regulation of feeding.
M D Turton, D O'Shea, I Gunn, S A Beak, C M Edwards, K Meeran, S J Choi, G M Taylor, M M Heath, P D Lambert,[...]. Nature 1996
9

Development and characterization of a glucagon-like peptide 1-albumin conjugate: the ability to activate the glucagon-like peptide 1 receptor in vivo.
Jung-Guk Kim, Laurie L Baggio, Dominique P Bridon, Jean-Paul Castaigne, Martin F Robitaille, Lucie Jetté, Corinne Benquet, Daniel J Drucker. Diabetes 2003
172
9

Expression of the GLP-1 receptor in mouse, rat, and human pancreas.
Ditte Tornehave, Peter Kristensen, John Rømer, Lotte Bjerre Knudsen, R Scott Heller. J Histochem Cytochem 2008
167
9

Cure of overt diabetes in NOD mice by transient treatment with anti-lymphocyte serum and exendin-4.
Norihiko Ogawa, James F List, Joel F Habener, Takashi Maki. Diabetes 2004
127
9

The multiple actions of GLP-1 on the process of glucose-stimulated insulin secretion.
Patrick E MacDonald, Wasim El-Kholy, Michael J Riedel, Anne Marie F Salapatek, Peter E Light, Michael B Wheeler. Diabetes 2002
325
9

Protein kinase Czeta activation mediates glucagon-like peptide-1-induced pancreatic beta-cell proliferation.
J Buteau, S Foisy, C J Rhodes, L Carpenter, T J Biden, M Prentki. Diabetes 2001
192
9

Mechanisms of action of glucagon-like peptide 1 in the pancreas.
Máire E Doyle, Josephine M Egan. Pharmacol Ther 2007
398
9

Glucagon-like peptide-1 mobilizes intracellular Ca2+ and stimulates mitochondrial ATP synthesis in pancreatic MIN6 beta-cells.
Takashi Tsuboi, Gabriela da Silva Xavier, George G Holz, Laurence S Jouaville, Andrew P Thomas, Guy A Rutter. Biochem J 2003
156
8

Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration.
L B Knudsen, P F Nielsen, P O Huusfeldt, N L Johansen, K Madsen, F Z Pedersen, H Thøgersen, M Wilken, H Agersø. J Med Chem 2000
447
8

Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients.
M B Toft-Nielsen, M B Damholt, S Madsbad, L M Hilsted, T E Hughes, B K Michelsen, J J Holst. J Clin Endocrinol Metab 2001
615
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.